The increasing concerns with antimicrobial resistance highlights the need for studies 17 evaluating the impacts of antimicrobial use in livestock on antimicrobial resistance using new 18 sequencing technologies. Through shotgun sequencing, we investigated the changes in the fecal 19 microbiome composition and function, with a focus on functions related to antimicrobial 20 resistance, of dairy calves. Heifers 2 to 3 weeks old, which were not treated with antibiotics by the 21 farm before enrollment, were randomly allocated to one of three study groups: control (no 22 treatment), enrofloxacin, or tulathromycin. Fecal samples were collected at days 4, 14, 56 and 112 23 days after enrollment, and DNA extraction and sample preparation and sequencing was conducted. 2 24 The effect of antibiotic treatment on each taxon and functional level by time (including Day 0 as 25 a covariate) revealed few changes in the microbiota. At the genus level, enrofloxacin group had 26 higher abundance of Blautia, Coprococcus and Desulfovibrio and lower abundance of Bacteroides 27
Introduction 43
There is urgent need for the judicious use of antimicrobial drugs to extend the effectiveness 44 of currently available therapies [1, 2] . Antimicrobial resistance (AMR) is a natural phenomenon, 6 114 farm employees and recorded in the farm's herd management software Valley 115 Ag Software, Tulare, CA, USA). The research group obtained these health-related and treatment 116 records from the herd management software and from the farm's drug use notebook to increase 117 data accuracy.
118
A randomized field trial study design was used. Calves 2 to 3 weeks old, which had not 119 been treated with antimicrobials before enrollment, were randomly allocated within cohort 120 (enrollment day) to one of three study groups: control (CON, no antimicrobial), enrofloxacin 121 (ENR, Baytril 100, Bayer Corp. Agricultural Division, Shawnee Mission, KS, USA) or 122 tulathromycin (TUL, Draxxin, Zoetis, Floham Park, NJ, USA). A total of 84 heifers were enrolled 123 in the trial: 26 allocated to CON, 28 to ENR and 27 to TUL, distributed in 6 cohorts (6 enrollment 124 days). Fecal samples were collected directly from the rectum of individual calves starting before 125 the administration of the antimicrobial treatment on enrollment day (Day 0) and on 4, 14, 56, and 126 112 days after enrollment. Fecal samples were transported in a cooler with ice packs to the 127 laboratory at the Cornell campus in Ithaca, NY, where they were aliquoted and stored at -20°C 128 until DNA extraction. For whole genome sequencing, a subset of 12 calves per study group was 7 137 to the PowerBead Tube, which was heat treated at 65°C for 10 minutes and then 95°C for 10 138 minutes. PowerBead Tubes were vortexed horizontally using the MoBio Vortex Adapter tube 139 holder at a maximum speed for 10 minutes. The remaining DNA extraction procedure followed 140 the standard protocol supplied by the kit manufacturer. The DNA concentration and purity were 141 evaluated by optical density using a NanoDrop ND-1000 spectrophotometer (NanoDrop 142 Technologies, Rockland, DE, USA) at wavelengths of 230, 260 and 280 nm. The eluted DNA was 143 stored at -20°C until further processing.
145

Library Preparation and Illumina HiSeq Sequencing
146
To increase measurement accuracy for the concentration for the DNA library, the starting 147 DNA library was quantified using a fluorometric-based method, the Qubit dsDNA HS Assay Due to the large number of comparisons, the hierarchical data was screened for effects and 183 only taxa or functions with a false discovery rate (FDR) P-value lower than 0.1 were selected for 184 the multivariable mixed logistic regression model. For each category, a model was fitted for the 185 most prevalent taxa or functions, the ones with significant FDR P-values or that were significant Figure S1 ).
221
Discriminant analysis was performed at the subsequent phylogenetic levels. At the genus level, the 222 differences were less pronounced compared to phylum level ( Figure S2 ). When looking at the effect of antibiotic treatment on each taxon individually, including 229 fixed and random effects, there was no significant effect of treatment group at the phylum level.
230
As already described, because of the difference in baseline value between treatment groups on Day 231 0, it was included in the mixed model as a covariate.
232
At the class level, on Day 56 there was a numerical increase in the abundance of 233 Deltaproteobacteria, which belongs to phylum Proteobacteria, for calves treated with enrofloxacin 234 when compared to both other treatment groups (P-value 0.093). The abundance of 235 Desulfovibrionales, an order within the Deltaproteobacteria phylum, was significantly different 236 among groups, being higher on Day 56 in calves treated with enrofloxacin (P-value 0.015). The 237 same significant trend was observed for the family Desulfovibrionaceae (P-value 0.010) and genus 238 Desulfovibrio (P-value 0.009), as shown in Figure 4 . 239 In the discriminant analysis, 16 unique genera were selected for the model (P-value < 0.1).
240
When evaluated using the multivariable mixed logistic regression model, only Bacteroides, 241 Blautia, Coprococcus and Desulfovibrio were significantly affected by treatment group and day 242 (P-values 0.035, 0.019, 0.027 and 0.009, respectively; Figure 4 ). At Level 2, calves in the enrofloxacin group had a higher abundance of genes with the 278 "Transposable elements" function, which is part of Level 1 category "Phages, Prophages,
279
Transposable elements, Plasmids", on Day 4 (P-value 0.034) and then reached levels similar to 280 the other two groups, as shown in Figure 7 . for the enrofloxacin group. Although calves that received enrofloxacin started with a higher 293 abundance of "RATC" on Day 0, we did not observe a rise in AMR genes after treatment with 294 enrofloxacin. According to the mixed model results, "RATC" was not statistically different among 295 the three treatment groups (P-value 0.095). A graph and a table with the relative abundances and 296 P-values can be found in Supplementary Figure 3 . At level 3, within "RATC", we found no significant difference in the relative abundance 302 of "Resistance to Fluoroquinolones" among treatment groups (P-value 0.19). Abundance of the 303 "RATC" function increased over time for all treatment groups, including for calves that did not 304 receive antibiotic treatment, and it was higher on Day 56 for calves treated with tulathromycin 305 (Figure 9 ). Also within "RATC", the relative abundance of "Multidrug efflux pump in 306 Campylobacter jejuni (CmeABC operon)" was significantly different among groups (P-value 307 0.015), with calves treated with enrofloxacin having higher abundance on Day 4 and then lower 308 on Day 56. There was no significant difference detected in "Erythromycin resistance" among 309 treatment groups (P-value 0.662). At the fourth and lowest functional level, the relatives abundances of "DNA gyrase subunit 320 A (EC 5.99.1.3)" within "Resistance to Fluoroquinolones" increased over time (P-value 0.037), 321 and of "rRNA adenine N-6-methyltransferase (EC 2.1.1.48)" within "Erythromycin resistance" 322 was significantly higher on Day 14 for the tulathromycin group, then it declined (P-values 0.026), 323 as picture in Figure 10 . Our results support that metaphylactic treatment of preweaned calves with enrofloxacin or 336 tulathromycin did not cause major changes in fecal microbiota composition and gene functions 337 related to antimicrobial resistance. Despite the fact that calves were not treated with antibiotics 338 before enrollment and were randomly assigned to one of the three study groups, these groups 339 started the trial with different microbiota composition and function, including higher abundances 340 of "Virulence, Disease and Defense" and "RATC" functions in calves assigned to enrofloxacin 341 treatment. Nevertheless, after controlling for this difference in the analysis, we did not observe a 342 significant increase in the abundance of genes with these functions after treatment with 343 antimicrobial drugs.
344
When lactating cows are treated with antimicrobial or other drugs due to illnesses, their 345 milk is withheld from sale because it may contain drug residues. This non-saleable milk, also called 346 waste milk, is often fed to calves. Antibiotic residues found in waste milk from 34 farms in New 347 York state were mainly β-lactams, tetracycline and sulfamethazine [25] . Enrofloxacin is approved 348 only for non-lactating female dairy cattle less than 20 months of age, and extra-label use of this 349 drug is strictly prohibited; therefore, there should not be residues from this drug class in milk fed 350 to calves. Additionally, enrofloxacin was not used at the study farm as a treatment for calf 351 pneumonia before the study began.
352
Calves could have acquired drug resistant bacteria and resistant genes from their mothers 353 during birth, from the waste milk used as feed [26, 27] 
362
The enrofloxacin group also had higher abundances of "Clustering-based subsystems" and lower fluoroquinolones" was found on the first day of life and increased over the following 6 weeks, 371 even in calves that did not receive any parenteral antimicrobial or drug residue in their milk [27] .
372
In our study, "Resistance to fluoroquinolones" was present even before the use of enrofloxacin on 373 Day 0, and increased over time, regardless of study group. This might be the result of co-resistance, 374 when bacteria acquire resistance to more than one class of antibiotic [35] . 
